Michael Barbella, Managing Editor06.02.22
NanoVibronix Inc. is giving U.S. military veterans access to more of its products.
The company's PainShield Plus and PainShield Monthly Kit products have been added to the Federal Supply Schedule (FSS) through a service disabled veteran organization. With these recent additions, NanoVibronix is able to make three of its products available to veterans, increasing access to non-opioid pain therapy and delivering positive patient outcomes. The two new products join the company’s UroShield urology therapy device and original PainShield MD product on the FSS.
“Our new additions to the FSS are an important achievement for NanoVibronix, further broadening our portfolio of products and the treatment options available to Veterans,” stated Brian Murphy, CEO of NanoVibronix. “We believe that our products deliver superior therapeutic value and are safe, easy-to-use, and highly effective in treating soft tissue pain. We are strongly encouraged by the early adoption that our products have received at the VA and look forward to further educating this important market on their long-term benefits.”
PainShield Plus utilizes ultrasound therapy for the treatment of pain and various soft tissue injuries either directly over joints or orthopedic hardware and without the need for messy ultrasound gels. The device is an effective solution for avoiding opioid treatments and supports social distancing by equipping patients to receive therapy independently in the comfort and safety of their own homes. Patient benefits include ease of application and use, faster recovery time, high compliance, and increased safety and efficacy over existing devices that rely on higher-frequency ultrasound.
NanoVibronix, Inc. is a medical device company headquartered in Elmsford, N.Y., with research and development in Nesher, Israel, focused on developing medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The proprietary technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The devices can be administered at home without the assistance of medical professionals. The company’s primary products include PainShield, UroShield, and WoundShield, all of which are portable devices suitable for administration at home without assistance of medical professionals.
The company's PainShield Plus and PainShield Monthly Kit products have been added to the Federal Supply Schedule (FSS) through a service disabled veteran organization. With these recent additions, NanoVibronix is able to make three of its products available to veterans, increasing access to non-opioid pain therapy and delivering positive patient outcomes. The two new products join the company’s UroShield urology therapy device and original PainShield MD product on the FSS.
“Our new additions to the FSS are an important achievement for NanoVibronix, further broadening our portfolio of products and the treatment options available to Veterans,” stated Brian Murphy, CEO of NanoVibronix. “We believe that our products deliver superior therapeutic value and are safe, easy-to-use, and highly effective in treating soft tissue pain. We are strongly encouraged by the early adoption that our products have received at the VA and look forward to further educating this important market on their long-term benefits.”
PainShield Plus utilizes ultrasound therapy for the treatment of pain and various soft tissue injuries either directly over joints or orthopedic hardware and without the need for messy ultrasound gels. The device is an effective solution for avoiding opioid treatments and supports social distancing by equipping patients to receive therapy independently in the comfort and safety of their own homes. Patient benefits include ease of application and use, faster recovery time, high compliance, and increased safety and efficacy over existing devices that rely on higher-frequency ultrasound.
NanoVibronix, Inc. is a medical device company headquartered in Elmsford, N.Y., with research and development in Nesher, Israel, focused on developing medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The proprietary technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The devices can be administered at home without the assistance of medical professionals. The company’s primary products include PainShield, UroShield, and WoundShield, all of which are portable devices suitable for administration at home without assistance of medical professionals.